Baxter recalls large number of units of sodium chloride and dextrose due to sterility concerns

The voluntary recall was posted in three separate notifications on the FDA’s website last week.

Baxter Pharmaceutical has issued a voluntary recall for more than 427,000 bags of 0.9% sodium chloride injection and 54,528 containers of 5% dextrose injection due to a lack of assurance of sterility and the possibility of leakage.

The voluntary recall was posted in three separate notifications on the FDA’s website last week.

The dextrose recall is for 100-ml Viaflex plastic containers distributed across the U.S., Puerto Rico and the United Arab Emirates.

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.

The recall for 427,104 bags of sodium chloride is for both 100 ml and 250 ml Viaflex container bags distributed mostly in the U.S. with some 100-ml bags in Puerto Rico and the UAE.

The recall initiation date for all three notices was July 6.

Read more on